CCCC
Price
$3.16
Change
+$0.27 (+9.34%)
Updated
Oct 20 closing price
Capitalization
388.76M
15 days until earnings call
Intraday BUY SELL Signals
SLDB
Price
$6.40
Change
+$0.48 (+8.11%)
Updated
Oct 20 closing price
Capitalization
686.24M
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs SLDB

CCCC vs SLDB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CCCC vs. SLDB commentary
Oct 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Buy and SLDB is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CCCC with price predictions
Oct 20, 2026

CCCC in -14.71% downward trend, sliding for three consecutive days on October 14, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CCCC declined for three days, in 314 of 341 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for CCCC entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CCCC's RSI Oscillator exited the oversold zone, 34 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 61 cases where CCCC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on CCCC as a result. In 69 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for CCCC just turned positive on October 19, 2026. Looking at past instances where CCCC's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.

Following a +14.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCCC advanced for three days, in 197 of 239 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

CCCC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.572) is normal, around the industry mean (3.009). P/E Ratio (-3.473) is within average values for comparable stocks, (-1.027). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.622) among similar stocks. P/S Ratio (10.989) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. CCCC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CCCC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for SLDB with price predictions
Oct 20, 2026

SLDB in +15.73% Uptrend, growing for three consecutive days on October 20, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SLDB advanced for three days, in 203 of 256 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SLDB's RSI Indicator exited the oversold zone, 33 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 55 cases where SLDB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

SLDB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day moving average for SLDB crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLDB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for SLDB entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.835) is normal, around the industry mean (3.009). P/E Ratio (-3.386) is within average values for comparable stocks, (-1.027). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.622) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. SLDB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLDB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
CCCC vs SLDB: Fundamental Ratings
CCCC
SLDB
OUTLOOK RATING
1..100
6559
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
32
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6265
P/E GROWTH RATING
1..100
2619
SEASONALITY SCORE
1..100
n/a23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CCCC's Valuation (29) in the null industry is in the same range as SLDB (32) in the Biotechnology industry. This means that CCCC’s stock grew similarly to SLDB’s over the last 12 months.

CCCC's Profit vs Risk Rating (100) in the null industry is in the same range as SLDB (100) in the Biotechnology industry. This means that CCCC’s stock grew similarly to SLDB’s over the last 12 months.

CCCC's SMR Rating (98) in the null industry is in the same range as SLDB (98) in the Biotechnology industry. This means that CCCC’s stock grew similarly to SLDB’s over the last 12 months.

CCCC's Price Growth Rating (62) in the null industry is in the same range as SLDB (65) in the Biotechnology industry. This means that CCCC’s stock grew similarly to SLDB’s over the last 12 months.

SLDB's P/E Growth Rating (19) in the Biotechnology industry is in the same range as CCCC (26) in the null industry. This means that SLDB’s stock grew similarly to CCCC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CCCCSLDB
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
COMPARISON
Comparison
Oct 21, 2026
Stock price -- (CCCC: $3.16 vs. SLDB: $6.40)
Brand notoriety: CCCC and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 149% vs. SLDB: 102%
Market capitalization -- CCCC: $388.76M vs. SLDB: $686.24M
CCCC [@Biotechnology] is valued at $388.76M. SLDB’s [@Biotechnology] market capitalization is $686.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.44B. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 2 FA rating(s) are green while SLDB’s FA Score has 2 green FA rating(s).

  • CCCC’s FA Score: 2 green, 3 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, both CCCC and SLDB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 6 TA indicator(s) are bullish while SLDB’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 6 bullish, 2 bearish.
  • SLDB’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than SLDB.

Price Growth

CCCC (@Biotechnology) experienced а +13.67% price change this week, while SLDB (@Biotechnology) price change was +9.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.45%. For the same industry, the average monthly price growth was -16.03%, and the average quarterly price growth was -14.84%.

Reported Earning Dates

CCCC is expected to report earnings on Nov 05, 2026.

SLDB is expected to report earnings on Nov 02, 2026.

Industries' Descriptions

@Biotechnology (-0.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CCCC
Daily Signal:
Gain/Loss:
SLDB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
YGG.X0.0249340.001403
+5.96%
Yield Guild Games cryptocurrency
ALGO.X0.1134950.003725
+3.39%
Algorand cryptocurrency
HNT.X0.4131140.009125
+2.26%
Helium cryptocurrency
REP.X0.4564080.005296
+1.17%
Augur cryptocurrency
TROY.X0.000003N/A
N/A
TROY cryptocurrency

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with RCKT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+9.34%
RCKT - CCCC
43%
Loosely correlated
+4.46%
FDMT - CCCC
42%
Loosely correlated
+6.59%
SLDB - CCCC
42%
Loosely correlated
+8.11%
SVRA - CCCC
41%
Loosely correlated
+2.81%
KYTX - CCCC
40%
Loosely correlated
+3.60%
More